Bio Essence Corp (BIOE) income statement
BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.42+0.03 (+7.72%)
Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –
Bio Essence Corp income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 68.4%
- Operating margin
- 45.1%
- Net margin
- 44.7%
- Return on equity, FY2025
- -35.5%
Financial strength
- Current ratio
- 0.17
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 12.2%
Valuation
- P/E ratio
- 10.5
- Price to sales
- 7.50
- Price to book
- 9.90
- Dividend yield
- –
See a number that looks wrong?